Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer
Front Oncol
.
2022 Sep 13:12:1022174.
doi: 10.3389/fonc.2022.1022174.
eCollection 2022.
Authors
Simone Patergnani
1
,
Donald J Buchsbaum
2
,
Gary A Piazza
3
Affiliations
1
Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Italy.
2
Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL, United States.
3
Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, United States.
PMID:
36176399
PMCID:
PMC9513571
DOI:
10.3389/fonc.2022.1022174
No abstract available
Keywords:
Wnt/β-catenin; cancer; molecular targets; signaling; targeted therapy.
Publication types
Editorial